NCT02783170View on ClinicalTrials.gov

Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 3, 2018

Study Completion Date

May 10, 2018

Conditions
Pregnancy
Interventions
BIOLOGICAL

Tetanus, Diphtheria, and Pertussis Vaccine

BIOLOGICAL

2016-2017 Quadrivalent Inactivated Influenza Vaccine

BIOLOGICAL

2017-2018 Quadrivalent Inactivated Influenza Vaccine

Trial Locations (3)

27705

Duke University, Durham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Unknown

Centers for Disease Control and Prevention, Atlanta

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Duke University

OTHER